|
|
Volumn 6, Issue 1, 2006, Pages 13-
|
|
Panitumumab: A new anti-EGFR antibody for the treatment of advanced colorectal cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
CETUXIMAB;
EPIDERMAL GROWTH FACTOR RECEPTOR;
FLUOROURACIL;
FOLINIC ACID;
IRINOTECAN;
OXALIPLATIN;
PANITUMUMAB;
ACNE;
ADVANCED CANCER;
CANCER COMBINATION CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL TRIAL;
COLORECTAL CANCER;
DRUG APPROVAL;
DRUG DOSE REGIMEN;
DRUG ERUPTION;
DRUG RESPONSE;
DRUG SAFETY;
DRUG TARGETING;
DRUG TOLERABILITY;
EDITORIAL;
ERYTHEMA;
HUMAN;
MONOTHERAPY;
PARONYCHIA;
QUALITY OF LIFE;
SALVAGE THERAPY;
SKIN PRURITUS;
SKIN TOXICITY;
STATISTICAL SIGNIFICANCE;
SURVIVAL RATE;
|
|
EID: 33745917044
PISSN: 15330028
EISSN: None
Source Type: Journal
DOI: 10.3816/CCC.2006.n.016 Document Type: Editorial |
|
Times cited : (5)
|
|
References (0)
|
